Table 3.
Perimount, n=102 | Perceval, n=102 | P-value | |
---|---|---|---|
XCT time isolated AVR † / minutes | 70.0 (58; 82) | 52 (43; 63) | <0.001* |
CPB time isolated AVR † / minutes | 91 (79; 103) | 82 (67; 96) | 0.012* |
XCT AVR + CABG / minutes | 107 (92; 123) | 74 (62; 91) | <0.001* |
CPB time AVR + CABG / minutes | 147 (118; 167) | 110 (80; 133) | <0.001* |
Minimally invasive / % (n) | 5% (5) | 28% (29) | <0.001* |
Isolated AVR † / % (n) | 58% (59) | 53% (54) | 0.481 |
Concomitant CABG / % (n) | 42% (43) | 47% (48) | |
Valve size 21 mm / % (n) | 15.7% (16) | 16.7% (17) | 0.802 |
Valve size 23 mm / % (n) | 36.3% (37) | 38.2% (39) | |
Valve size 25 mm / % (n) | 39.2% (40) | 33.3% (34) | |
Valve size 27 mm / % (n) | 8.8% (9) | 11.8% (12) |
† Some patients received other short, non-CABG procedures in addition to AVR: Perimount: 3 x LAA clip + ablation, 1 x LAA clip, 1 x AMVL decalcification, 1 x septal myotomy; Perceval: 3 x LAA clip, 1 x AMVL decalcification, 1 x LAA clip + ablation, 1 x ablation; note that 1 patient with CABG also received ablation
Values: median (LQ to UQ) or % (n). * P <0.05
XCT: cross-clamp time, CPB: cardiopulmonary bypass, AVR: aortic valve replacement, CABG: coronary artery bypass graft, MVR: mitral valve replacement